Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07572513 · ClinicalTrials.gov registry record · NA
Slowly Digestible Carbohydrates for GLP-1 Secretion
A NA study, sponsored by Purdue University.
- Recruiting
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT07572513 is a NA study that is actively recruiting participants, run by Purdue University. The registered enrollment target is 19 participants.
The verdict
NCT07572513, a NA study, is actively recruiting participants, sponsored by Purdue University.
- RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of this clinical trail is to learn if the hormone, glucagon-like peptide-1 (GLP-1), is stimulated by slowly digestible carbohydrates (SDCs) in healthy adults. In the current study, researchers will observe the amount of SDC that results in clinically meaningful levels of GLP-1, shown by an increase in feelings of fullness and a decrease in hunger, and how long an elevated level of GLP-1 lasts after starch consumption. Researchers aim to address two questions: What amount of SDC maximizes GLP-1-mediated satiety, and does the impact to satiety continue in a second meal? The overall goal is to maximize ileal-digesting SDC's potential use as a food-based agent for weight loss. Researchers will compare 20, 40, and 60 g of raw corn starch compared to a maltodextrin control on total plasma GLP-1 concentrations, insulin, and blood glucose at baseline and 15, 30, 60, 90, 120, and 180 minutes post-consumption of SDC. Researchers will also measure satiety at baseline, 60, 120, 180 minutes and after a second meal. There will be a total of 4 study visits with a least a 7-day break between visits. At each study visit, participants will: * Consume a randomized test beverage (SDC or maltodextrin) * Receive a blood draw at 7 timepoints over 3 hrs * Take a satiety questionnaire 5 times over 3 hrs * Consume a standardized lunch 3 hrs after the test beverage consumption
Interventions
- DIETARY_SUPPLEMENT Maltodextrin (Placebo)
- DIETARY_SUPPLEMENT Raw Corn Starch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2026-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07572513
The ClinicalTrials.gov registry entry for NCT07572513 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maltodextrin (Placebo) is the first listed.
NCT07572513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07572513 about?
NCT07572513 is a clinical study titled "Slowly Digestible Carbohydrates for GLP-1 Secretion". The goal of this clinical trail is to learn if the hormone, glucagon-like peptide-1 (GLP-1), is stimulated by slowly digestible carbohydrates (SDCs) in healthy adults. In the current study, researchers will observe the amount of SDC that results in clinically meaningful levels of GLP-1, shown by an ...
What is the current status of trial NCT07572513?
This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2026-05-01. Estimated completion is 2026-11-25.
What interventions are being tested in trial NCT07572513?
The interventions under investigation include: Maltodextrin (Placebo) (DIETARY_SUPPLEMENT), Raw Corn Starch (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07572513?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.